Gilenya safety update: cardiac and macula

Curr Opin Ophthalmol. 2012 Nov;23(6):457-9. doi: 10.1097/ICU.0b013e3283590bda.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Bradycardia / chemically induced*
  • Drug Monitoring
  • Fingolimod Hydrochloride
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Macular Edema / chemically induced*
  • Multiple Sclerosis / drug therapy
  • Propylene Glycols / adverse effects*
  • Propylene Glycols / therapeutic use
  • Sphingosine / adverse effects
  • Sphingosine / analogs & derivatives*
  • Sphingosine / therapeutic use

Substances

  • Immunosuppressive Agents
  • Propylene Glycols
  • Fingolimod Hydrochloride
  • Sphingosine